These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 34406036)

  • 1. Fast and Efficient Generation of Isogenic Induced Pluripotent Stem Cell Lines Using Adenine Base Editing.
    Nami F; Ramezankhani R; Vandenabeele M; Vervliet T; Vogels K; Urano F; Verfaillie C
    CRISPR J; 2021 Aug; 4(4):502-518. PubMed ID: 34406036
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficient Generation and Correction of Mutations in Human iPS Cells Utilizing mRNAs of CRISPR Base Editors and Prime Editors.
    Sürün D; Schneider A; Mircetic J; Neumann K; Lansing F; Paszkowski-Rogacz M; Hänchen V; Lee-Kirsch MA; Buchholz F
    Genes (Basel); 2020 May; 11(5):. PubMed ID: 32384610
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficient Cas9-based Genome Editing Using CRISPR Analysis Webtools in Severe Early-onset-obesity Patient-derived iPSCs.
    Patel A; Iannello G; Diaz AG; Sirabella D; Thaker V; Corneo B
    Curr Protoc; 2022 Aug; 2(8):e519. PubMed ID: 35950852
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gene editing and clonal isolation of human induced pluripotent stem cells using CRISPR/Cas9.
    Yumlu S; Stumm J; Bashir S; Dreyer AK; Lisowski P; Danner E; Kühn R
    Methods; 2017 May; 121-122():29-44. PubMed ID: 28522326
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Determining the Pathogenicity of a Genomic Variant of Uncertain Significance Using CRISPR/Cas9 and Human-Induced Pluripotent Stem Cells.
    Ma N; Zhang JZ; Itzhaki I; Zhang SL; Chen H; Haddad F; Kitani T; Wilson KD; Tian L; Shrestha R; Wu H; Lam CK; Sayed N; Wu JC
    Circulation; 2018 Dec; 138(23):2666-2681. PubMed ID: 29914921
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficient introduction of specific homozygous and heterozygous mutations using CRISPR/Cas9.
    Paquet D; Kwart D; Chen A; Sproul A; Jacob S; Teo S; Olsen KM; Gregg A; Noggle S; Tessier-Lavigne M
    Nature; 2016 May; 533(7601):125-9. PubMed ID: 27120160
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gene Editing in Human Induced Pluripotent Stem Cells Using Doxycycline-Inducible CRISPR-Cas9 System.
    Thamodaran V; Rani S; Velayudhan SR
    Methods Mol Biol; 2022; 2454():755-773. PubMed ID: 33830454
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Editing the Genome of Human Induced Pluripotent Stem Cells Using CRISPR/Cas9 Ribonucleoprotein Complexes.
    Bruntraeger M; Byrne M; Long K; Bassett AR
    Methods Mol Biol; 2019; 1961():153-183. PubMed ID: 30912046
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficient gene editing in induced pluripotent stem cells enabled by an inducible adenine base editor with tunable expression.
    Nandy K; Babu D; Rani S; Joshi G; Ijee S; George A; Palani D; Premkumar C; Rajesh P; Vijayanand S; David E; Murugesan M; Velayudhan SR
    Sci Rep; 2023 Dec; 13(1):21953. PubMed ID: 38081875
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rapid Generation of Human Genetic Loss-of-Function iPSC Lines by Simultaneous Reprogramming and Gene Editing.
    Tidball AM; Dang LT; Glenn TW; Kilbane EG; Klarr DJ; Margolis JL; Uhler MD; Parent JM
    Stem Cell Reports; 2017 Sep; 9(3):725-731. PubMed ID: 28781079
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Homozygous might be hemizygous: CRISPR/Cas9 editing in iPSCs results in detrimental on-target defects that escape standard quality controls.
    Simkin D; Papakis V; Bustos BI; Ambrosi CM; Ryan SJ; Baru V; Williams LA; Dempsey GT; McManus OB; Landers JE; Lubbe SJ; George AL; Kiskinis E
    Stem Cell Reports; 2022 Apr; 17(4):993-1008. PubMed ID: 35276091
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro genome editing rescues parkinsonism phenotypes in induced pluripotent stem cells-derived dopaminergic neurons carrying LRRK2 p.G2019S mutation.
    Chang KH; Huang CY; Ou-Yang CH; Ho CH; Lin HY; Hsu CL; Chen YT; Chou YC; Chen YJ; Chen Y; Lin JL; Wang JK; Lin PW; Lin YR; Lin MH; Tseng CK; Lin CH
    Stem Cell Res Ther; 2021 Sep; 12(1):508. PubMed ID: 34551822
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cytosine and adenosine base editing in human pluripotent stem cells using transient reporters for editing enrichment.
    Tekel SJ; Brookhouser N; Standage-Beier K; Wang X; Brafman DA
    Nat Protoc; 2021 Jul; 16(7):3596-3624. PubMed ID: 34172975
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CRISPRi/a Screening with Human iPSCs.
    Nishiga M; Qi LS; Wu JC
    Methods Mol Biol; 2021; 2320():261-281. PubMed ID: 34302664
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of single guided Cas9 nickase to facilitate precise and efficient genome editing in human iPSCs.
    Li PP; Margolis RL
    Sci Rep; 2021 May; 11(1):9865. PubMed ID: 33972655
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Using CRISPR-Cas9 to Generate Gene-Corrected Autologous iPSCs for the Treatment of Inherited Retinal Degeneration.
    Burnight ER; Gupta M; Wiley LA; Anfinson KR; Tran A; Triboulet R; Hoffmann JM; Klaahsen DL; Andorf JL; Jiao C; Sohn EH; Adur MK; Ross JW; Mullins RF; Daley GQ; Schlaeger TM; Stone EM; Tucker BA
    Mol Ther; 2017 Sep; 25(9):1999-2013. PubMed ID: 28619647
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comprehensive Protocols for CRISPR/Cas9-based Gene Editing in Human Pluripotent Stem Cells.
    Santos DP; Kiskinis E; Eggan K; Merkle FT
    Curr Protoc Stem Cell Biol; 2016 Aug; 38():5B.6.1-5B.6.60. PubMed ID: 27532820
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adenine base editing reduces misfolded protein accumulation and toxicity in alpha-1 antitrypsin deficient patient iPSC-hepatocytes.
    Werder RB; Kaserman JE; Packer MS; Lindstrom-Vautrin J; Villacorta-Martin C; Young LE; Aratyn-Schaus Y; Gregoire F; Wilson AA
    Mol Ther; 2021 Nov; 29(11):3219-3229. PubMed ID: 34217893
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CRISPR/Cas9 Genome Editing of Human-Induced Pluripotent Stem Cells Followed by Granulocytic Differentiation.
    Dannenmann B; Nasri M; Welte K; Skokowa J
    Methods Mol Biol; 2020; 2115():471-483. PubMed ID: 32006418
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A simple, quick, and efficient CRISPR/Cas9 genome editing method for human induced pluripotent stem cells.
    Geng BC; Choi KH; Wang SZ; Chen P; Pan XD; Dong NG; Ko JK; Zhu H
    Acta Pharmacol Sin; 2020 Nov; 41(11):1427-1432. PubMed ID: 32555510
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.